Redesigned catheter aims to make angiograms safer and more precise

NCT ID NCT06986954

Completed Knowledge-focused Sponsor: Cook Research Incorporated Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study follows about 800 people undergoing angiographic procedures with redesigned Beacon Tip catheters. The goal is to see if the catheters can be safely navigated to the intended location and used for tasks like releasing contrast dye or taking anatomical measurements. Researchers will track major complications within 30 days of the procedure. The data will be used to support regulatory approval in Europe and other regions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Beacon Tip Catheters (device)
What this could lead to: If successful, this study could support regulatory approval for improved catheters that help doctors perform angiograms and anatomical measurements more safely.
What could go wrong: This is an observational study, not a controlled trial, so results may not prove the device is better than others. Complications like bleeding or stroke are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLEED INTRACRANIAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aneurysm, False Constriction, Pathologic intracerebral hemorrhage Intracranial Hemorrhages stroke disorder transient ischemic attack vascular malformation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLEED INTRACRANIAL PSEUDOANEURYSM STENOSIS STROKE TIA VASCULAR MALFORMATION

Contacts and locations

Show contact details

Locations

Vascular Breakthroughs

Darien, Connecticut, 06820, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.